Close Menu

Pathogenetix

Next month, Toxic Reports plans to fully launch the pathogen identification platform developed by PathoGenetix, which went belly up in the summer. 

NEW YORK (GenomeWeb) – PathoGenetix has filed for Chapter 7 bankruptcy in US Bankruptcy Court District of Massachusetts.

NEW YORK (GenomeWeb News) – PathoGenetix said today that it has tapped Sparton to design and manufacture pre-commercial instruments for its Resolution Microbial Genotyping System for detecting microbial pathogens in food.

NEW YORK (GenomeWeb News) – PathoGenetix today said that Marshfield Food Safety will evaluate and provide feedback on PathoGenetix's Resolution Microbial Genotyping System.

NEW YORK (GenomeWeb News) – PathoGenetix today announced it has secured $10 million in Series C financing to further commercialization efforts for its Genome Sequence Scanning technology.

NEW YORK (GenomeWeb News) – Sequencing technology firm PathoGenetix has raised $3.6 million, it said in a regulatory filing.

This article was originally published Oct. 7.

NEW YORK (GenomeWeb News) – PathoGenetix and the US Department of Agriculture's Agricultural Research Service announced late on Monday the evaluation of PathoGenetix's technology for identifying strains of Shiga-toxin-producing E. coli, or STECs, and Salmonella enterica.

NEW YORK (GenomeWeb News) – PathoGenetix and Applied Maths today announced a deal to integrate each other's technologies into a solution for rapid pathogen strain typing.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.